Endothelial cells lining the blood vessels of a donor organ are the major target of immunity and an important effector of tissue injury in xenogeneic organ grafts. The overall objective of this project is to elucidate how endothelial cells mediated xenograft rejection. Xenograft rejection is triggered by the reaction of recipient antibodies and complement with donor endothelial cells. This reaction leads very rapidly to thrombosis and a loss of vascular integrity. The first objective of the project will be to discover how the binding of antibodies and the activation of complement might cause changes in the morphology of endothelial cells or the loss of heparan sulfate from the cells which would lead to these pathological changes. The second objective of the project is to study the pathogenesis of acute vascular rejection. The hypothesis is put forward that this type of rejection reflects the activation of graft endothelial cells due to the prolonged interaction with recipient antibodies and complement. This hypothesis will be pursued by studying manifestations of endothelial cell activation in cultured pig endothelial cells mediated by the binding of human antibodies and the activation of complement components. The manifestations to be studied include prothrombotic changes such as he increase in tissue factor and decrease in thrombomodulin, proinflammatory changes such as the synthesis of cytokines and elaboration of cell adhesion molecules and changes in the barrier properties of a cultured monolayer. The third objective of the project is to elucidate the mechanism behind the phenomenon of """"""""accommodation."""""""" Accommodation reflects an acquired resistance of endothelial cells to injury caused by antibody binding and complement activation. This change may result from a decrease in the sensitivity of endothelial cells to humoral injury or an increase in the production of protective factors. A better understanding of the mechanisms of endothelial cell injury in xenotransplantation may contribute to the clinical application of xenotransplantation and also toward a further understanding of the mechanisms underlying vascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL050985-04
Application #
6242263
Study Section
Project Start
1997-02-01
Project End
1998-01-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Lee, Winston; Gaca, Jeffrey G; Edwards, Lindsay A et al. (2002) Binding of polyreactive antibodies to self versus foreign antigens. Immunobiology 205:95-107
Parker, W; Lin, S S; Platt, J L (2001) Antigen expression in xenotransplantation: how low must it go? Transplantation 71:313-9
Langdon, S D; Inaioki, M; Kelsoe, G et al. (2000) Germline sequences of V(H)7183 gene family members in C57BL/6 mice demonstrate natural selection of particular sequences during recent evolution. Immunogenetics 51:241-5
Lau, C L; Daggett, W C; Yeatman, M F et al. (2000) The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. J Thorac Cardiovasc Surg 120:29-38
Yan, Z Q; Bolognesi, M P; Steeber, D A et al. (2000) Blockade of L-selectin attenuates reperfusion injury in a rat model. J Reconstr Microsurg 16:227-33
Nagaoka, T; Kaburagi, Y; Hamaguchi, Y et al. (2000) Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol 157:237-47
Parker, W; Lin, S S; Yu, P B et al. (1999) Naturally occurring anti-alpha-galactosyl antibodies: relationship to xenoreactive anti-alpha-galactosyl antibodies. Glycobiology 9:865-73
Li, X; Tedder, T F (1999) CHST1 and CHST2 sulfotransferases expressed by human vascular endothelial cells: cDNA cloning, expression, and chromosomal localization. Genomics 55:345-7
Tu, L; Murphy, P G; Li, X et al. (1999) L-selectin ligands expressed by human leukocytes are HECA-452 antibody-defined carbohydrate epitopes preferentially displayed by P-selectin glycoprotein ligand-1. J Immunol 163:5070-8
Gonzalez-Stawinski, G V; Parker, W; Holzknecht, Z E et al. (1999) Partial sequence of human platelet heparitinase and evidence of its ability to polymerize. Biochim Biophys Acta 1429:431-8

Showing the most recent 10 out of 141 publications